Dubai, UAE: Leading family-owned holding company GMG has confirmed plans to further expand its health-related business as the industry undergoes an unprecedented transformation. The conglomerate’s health vertical is on track to expand its retail footprint in the UAE by more than 40% by the end of 2022.

Against the backdrop of the COVID-19 pandemic, the health industry has experienced a paradigm shift from curative to preventative care, with more consumers actively changing their approach to fitness and wellbeing. According to a recent industry report, healthcare expenditure across the GCC will touch $89 billion by 2022[1]. Another global survey recently revealed changing consumer habits, with 62% of individuals saying that they have made significant lifestyle changes towards improving their health[2]. Approximately one in three say they’re eating healthier food, while 28% say they have increased their exercise frequency during the pandemic.

GMG’s health business is in turn gearing up for a surge in consumer demand for quality health and wellbeing products and services. The company’s health portfolio currently includes prominent homegrown concepts like Supercare Pharmacy, Good Health, and Arabella Pharmacy. Supercare is a leading healthcare, lifestyle, and pharma care company with a legacy of over 40 years. Good Health is a more recent pioneer in herbal remedies and dietary supplements, while Arabella Pharmacy provides natural, organic health products.

Mohammad A. Baker, Deputy Chairman and CEO of GMG, said: “The healthcare industry in the UAE and the wider Middle East region is transforming at a rapid pace, with consumer behavior shifting towards preventative care. Through our diversified portfolio of health concepts, GMG is ensuring that we take proactive steps to fulfill growing consumer needs while inspiring good health and wellbeing. With our expansion, we are continuing to contribute to the development of the UAE society, in line with its national ambition of building a world-class healthcare industry.”

GMG’s first foray into the health and pharma industry was in 1980 when it launched the Al Khayyam Pharmacy to improve access to medicine in Dubai, UAE. A decade later, Al Khayyam Pharmacy was rebranded to Supercare Pharmacy, and its reach gradually expanded across the UAE. The conglomerate introduced its homegrown concept Good Health in 1992, and relaunched Arabella Pharmacy this year.

Over the last several years, GMG has been expanding its global operations with a diversified portfolio of brands that now covers industries such as sports, food, and health. Operating across the GCC region and internationally, GMG has introduced more than 90 brands into the Middle East while also creating reliable and quality-driven homegrown brands.


About Gulf Marketing Group (GMG) 

Gulf Marketing Group oversees a diverse portfolio of international brands and homegrown concepts across key industry sectors, with the aim of making the world a better place. Under the ownership and management of the Baker family, it has become one of the Middle East’s leading family-owned holding companies affiliated with the world’s most successful and respected brands. Operating across the GCC region and internationally, GMG has introduced more than 90 brands into the Middle East, while also creating reliable and quality-driven homegrown brands. 

For more information please contact: 

Send us your press releases to

© Press Release 2021

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.